Similar articles

• Sustained virological response to treatment in patients with chronic hepatitis C--reply.

  van der Meer AJ, Hansen BE, Janssen HL. van der Meer AJ, et al. JAMA. 2013 Apr 10;309(14):1457. doi: 10.1001/jama.2013.2733. JAMA. 2013. PMID: 23571571 No abstract available.
• Impact of sustained virologic response on all-cause mortality.

  Backus LI, Belperio PS. Backus LI, et al. Hepatology. 2013 Oct;58(4):1508-10. doi: 10.1002/hep.26504. Epub 2013 Aug 6. Hepatology. 2013. PMID: 23703903 No abstract available.
• Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

  van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, Duarte-Rojo A, Heathcote EJ, Manns MP, Kuske L, Zeuzem S, Hofmann WP, de Knegt RJ, Hansen BE, Janssen HL. van der Meer AJ, et al. JAMA. 2012 Dec 26;308(24):2584-93. doi: 10.1001/jama.2012.144878. JAMA. 2012. PMID: 23268517
• Viral hepatitis and hepatocellular carcinoma.

  Marrero CR, Marrero JA. Marrero CR, et al. Arch Med Res. 2007 Aug;38(6):612-20. doi: 10.1016/j.arcmed.2006.09.004. Arch Med Res. 2007. PMID: 17613352 Review.
• Management of the patient with SVR.

  Terrault NA, Hassanein TI. Terrault NA, et al. J Hepatol. 2016 Oct;65(1 Suppl):S120-S129. doi: 10.1016/j.jhep.2016.08.001. J Hepatol. 2016. PMID: 27641982 Review.